Warning: Trying to access array offset on value of type bool in /bitnami/wordpress/wp-content/themes/the-newspaper/theme-framework/theme-style/function/template-functions.php on line 673

Last week, we reported in the Trends Journal that blood clotting after receiving the AstraZeneca vaccine caused a number of European countries to halt further shots until more data could be collected (See our article, “VACCINE HALTED IN EUROPE.”)
Last Saturday, Denmark reported another death and one case of blood clotting with cerebral hemorrhage from the shot. Both were hospital staff. Reuters reported on Saturday that the acting Director of Pharmacovigilance at the Danish Medicines Agency, Tanja Erichsen, stated,
“We prioritize reports of suspected serious side effects such as these and examine them thoroughly to assess whether there is a possible link to the vaccine.”
Sweden and Norway issued statements on Friday also citing additional research was required before deciding to resume this vaccine. A Norwegian medical team, according to Reuters, “Concluded that the hospitalizations of three medical workers there, including one who died, were probably caused by an immune response to the vaccine.”
While Germany was among some EU countries confident enough to allow a full return to AstraZeneca shots, confusion reigns, as EU countries differ on how much to trust the opinions of EU’s Medicines Agency (EMA).
Making it Up as They Go Along
In France, Reuters reported on Friday that the country’s medical regulator “approved the resumption of AstraZeneca vaccinations on Friday, but in a break with guidance from the European watchdog said it should be given only to people aged 55 and older.”
Adding to the confusion, as Reuters reported,
“On Thursday, the European Medicines Agency said the vaccine was safe for all age groups. It said it was convinced the benefits outweighed the risks after reports of rare instances of blood clotting. However, France’s National Authority for Health (HAS) took note of evidence that the clotting affected younger people mostly, whose risk of dying from COVID-19 was lower than the elderly, and departed from the EMA’s line….
‘When it comes to AstraZeneca, I have to say I sympathize with those who struggle to make sense of it all,’ said Marie-Louise Pradin, a doctor based in the northern city of Lille.”
The Washington Post report last Thursday confirmed the confusion:
“The decisions to pause use of the AstraZeneca vaccine had divided both the scientific community and Europe. Some experts have argued that the extremely unusual and deadly nature of blood clots detected, even if in tiny numbers, warrant caution. Others said hasty decisions will have an irreparable effect on confidence in the vaccine.”
TRENDPOST: To promote the use of the controversial AstraZeneca vaccine, on Friday, both U.K. Prime Minister Boris Johnson and French Prime Minister Jean Castex were given major media coverage, showing the squeamish boys with their masks on and flabby arms (supposedly) getting jabbed with the shot. 
Don’t Shoot Me
On Friday, CNN reported:
“Despite a massive effort by the Pentagon to promote the safety and efficacy of COVID-19 vaccines, the US military’s opt-out rate for vaccinations may be far higher than the 33% figure defense officials have used publicly… Conversations with military medical officials and service members, as well as data from several bases and units around the country, suggest the current rejection rate may be closer to 50%.”
TREND FORECAST: As we have reported and the data proves, the vast majority of the coronavirus deaths are the elderly and those suffering from at least 2.6 preexisting chronic conditions. Thus, as evidenced this past weekend in Miami, where a state of emergency was called because the city could not control the masses of young people celebrating an “anything goes” Spring Break/party attitude, to them it’s an “old person’s disease.” 
Same, too, with the military. Since some 50 percent of all military personnel are under the age of 25 and over 80 percent are under 35, according to CNN, most of the anti-vax resistance is coming from younger troop members. “The depressed vaccine acceptance rate is driven largely by a hesitancy among younger service members. Officials who spoke to CNN say younger troops generally feel Covid-19 poses little risk to them.”
And, since military protocol states that any vaccine released under the Emergency Use Authorization of the FDA, such as the COVID-19 vaccines, cannot be made mandatory, that will change if/when the FDA changes the status of the vaccine to mandatory. Thus, the troops would be forced to get injected. 

Comments are closed.

Skip to content